| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | ||||||||||
30,467 | 56,535 | 45,166 | 55,161 | 73,664 | 79,017 | 109,338 | 97,644 | 93,668 | 81,795 | 71,397 |
Costs and expenses: | ||||||||||
Cost of sales | ||||||||||
19,637 | 36,471 | 27,144 | 36,367 | 45,107 | 43,889 | 62,521 | 56,899 | 49,857 | 46,821 | 42,444 |
Selling, general and administrative | ||||||||||
17,191 | 18,564 | 20,933 | 25,564 | 30,897 | 35,432 | 36,375 | 32,682 | 33,446 | 30,857 | 32,273 |
Restructuring charge | ||||||||||
625 | 0 | 119 | 1,428 | 219 | - | - | - | - | - | - |
Restructuring charge | ||||||||||
- | - | - | - | - | 0 | - | - | - | - | - |
Gain on revaluation of ACT liability | ||||||||||
- | - | - | - | - | - | - | - | 758 | 768 | - |
Gain on revaluation of ACT liability | ||||||||||
- | - | - | - | - | - | - | - | - | - | 781 |
Research and development | ||||||||||
1,127 | 1,073 | 1,070 | 1,752 | 1,447 | 1,459 | 2,442 | 2,863 | 1,474 | 948 | 542 |
Intangible assets abandonment and building impairment | ||||||||||
127 | 317 | 2,965 | 2,074 | 1,425 | - | - | - | - | - | - |
Goodwill and intangible assets impairment | ||||||||||
- | - | - | - | - | 23,400 | 0 | - | - | - | - |
Goodwill impairment | ||||||||||
- | - | - | - | - | - | - | 0 | - | - | - |
Costs and expenses: | ||||||||||
38,707 | 56,425 | 52,231 | 67,185 | 79,095 | 104,180 | 101,338 | 92,444 | 84,019 | 77,858 | - |
- | - | - | - | - | - | - | - | - | - | 74,478 |
Operating loss from continuing operations | ||||||||||
-8,240 | 110 | -7,065 | -12,024 | -5,431 | -25,163 | 8,000 | 5,200 | 9,649 | 3,937 | -3,081 |
Interest expense | ||||||||||
- | - | - | - | 27 | 125 | 56 | 93 | 148 | 143 | 120 |
Interest income | ||||||||||
41 | 6 | 10 | 25 | 21 | 29 | 58 | 78 | 35 | 11 | 32 |
Foreign exchange gain | ||||||||||
370 | 0 | 0 | - | - | - | - | - | - | - | - |
Other income | ||||||||||
-8 | 2 | -60 | -925 | -360 | -544 | -137 | -107 | -279 | -119 | -241 |
Loss from continuing operations before income taxes | ||||||||||
-7,837 | 118 | -7,115 | -12,924 | -5,797 | -25,803 | 7,865 | 5,078 | 9,257 | 3,686 | -3,410 |
Income tax expense | ||||||||||
14 | 33 | -580 | 1,664 | 3,757 | -8,078 | 2,764 | 2,302 | 3,109 | 1,933 | -1,104 |
Net loss from continuing operations | ||||||||||
-7,851 | 85 | -6,535 | -14,588 | -9,554 | - | - | - | - | - | - |
Loss from discontinued operations (net of income tax benefit of $0 in 2020 and 2019) | ||||||||||
-1 | -113 | -3,914 | -2,800 | -2,826 | - | - | - | - | - | - |
Net loss | ||||||||||
-7,852 | -28 | -10,449 | -17,388 | -12,380 | -17,725 | 5,101 | 2,776 | 6,148 | 1,753 | -2,306 |
Net loss per common share: | ||||||||||
Net loss per common share: | ||||||||||
Basic | ||||||||||
Continuing operations (in dollars per share) | ||||||||||
-0.32 | 0.00 | -0.28 | -0.62 | -0.42 | - | - | - | - | - | - |
Discontinued operations (in dollars per share) | ||||||||||
0.00 | 0.00 | -0.16 | -0.12 | -0.12 | - | - | - | - | - | - |
Basic net loss per common share (in dollars per share) | ||||||||||
-0.32 | 0.00 | -0.44 | -0.01 | -0.54 | -0.78 | 0.23 | 0.12 | 0.26 | 0.07 | -0.10 |
Diluted | ||||||||||
Continuing operations (in dollars per share) | ||||||||||
-0.32 | 0.00 | -0.28 | -0.62 | -0.42 | - | - | - | - | - | - |
Discontinued operations (in dollars per share) | ||||||||||
0.00 | 0.00 | -0.16 | -0.12 | -0.12 | - | - | - | - | - | - |
Diluted net loss per common share (in dollars per share) | ||||||||||
-0.32 | 0.00 | -0.44 | -0.74 | -0.54 | -0.78 | 0.23 | 0.12 | 0.25 | 0.07 | -0.10 |
Weighted-average number of common shares outstanding: | ||||||||||
Weighted-average number of common shares outstanding: | ||||||||||
Basic (in shares) | ||||||||||
24,202 | 24,164 | 23,872 | 23,365 | 23,101 | 22,782 | 22,286 | 22,709 | 24,095 | 24,213 | 24,148 |
Diluted (in shares) | ||||||||||
24,202 | 24,164 | 23,872 | 23,365 | 23,101 | 22,782 | 22,579 | 23,535 | 24,633 | 24,405 | 24,148 |